Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.07
-0.1500-6.76%
Post-market: 2.070.00000.00%18:57 EDT
Volume:833.40K
Turnover:1.80M
Market Cap:149.48M
PE:-1.26
High:2.29
Open:2.22
Low:2.07
Close:2.22
52wk High:3.60
52wk Low:1.50
Shares:72.21M
Float Shares:37.05M
Volume Ratio:1.06
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:2.61
PE(LYR):-1.03

Loading ...

Sep 16, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 31, 2026

Correspondence

Form CORRESP - Correspondence
Mar 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2026

Major Issues Report

Form 8-K - Current report
Mar 16, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities